Author

Zhi-Hong Dai

h-index 5 View on Semantic Scholar

We have 3 of 33 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Curcumin inhibits atherosclerotic plaque formation by regulating PLCG2 ubiquitination in vascular smooth muscle cells.

Atherosclerosis (AS) is a chronic inflammatory disease in which vascular smooth muscle cell (VSMC) pyroptosis and foam cell formation play critical roles. Curcumin has anti-atherosclerotic effects, but its molecular mechanism remains unclear. In this study, we investigated whether and how curcumin regulates VSMC pyropt...

Lin Xie, Xuan Zeng, Yun-Xian Wu et al. · International Immunopharmaco... · 0 citations

Case report Open access Aug 2026

Xanthogranulomatous prostatitis mimicking prostate carcinoma: a case report and comprehensive literature review

Introduction Granulomatous prostatitis (GP) is a relatively uncommon disorder, accounting for approximately 0. 8% to 1.0% of all benign inflammatory prostatic conditions. Xanthogranulomatous prostatitis (XGP) is an exceptionally rare subtype of GP, with only a limited number of cases documented in the medical literatur...

Ming-Feng Ji, Yi-Hao Chen, Hao-Xuan Feng et al. · Frontiers in Medicine · 0 citations

Open access Aug 2026

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

These findings identify AR/ZNF217/PROM2 signaling as a central determinant of ferroptotic vulnerability in prostate cancer and suggest that targeting this pathway may enhance sensitivity to AR inhibition, providing a molecular rationale for combination therapy in castration-resistant prostate cancer.

Wenjun Hao, Peng Liang, Wanglong Zheng et al. · Oncogenesis · 0 citations